Mouse models of experimental atherosclerosis J Jawien, P Nastalek, R Korbut Journal of physiology and pharmacology 55 (3), 503-517, 2004 | 560 | 2004 |
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice R Elhage, J Jawien, M Rudling, HG Ljunggren, K Takeda, S Akira, ... Cardiovascular research 59 (1), 234-240, 2003 | 506 | 2003 |
IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells C Tenger, A Sundborger, J Jawien, X Zhou Arteriosclerosis, thrombosis, and vascular biology 25 (4), 791-796, 2005 | 239 | 2005 |
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. R Olszanecki, J Jawień, M Gajda, L Mateuszuk, A Gebska, ... Journal of physiology and pharmacology: an official journal of the Polish …, 2005 | 213 | 2005 |
Deleting TCRαβ+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice R Elhage, P Gourdy, L Brouchet, J Jawien, MJ Fouque, C Fiévet, X Huc, ... The American journal of pathology 165 (6), 2013-2018, 2004 | 161 | 2004 |
Inhibition of five lipoxygenase activating protein (FLAP) by MK‐886 decreases atherosclerosis in apoE/LDLR‐double knockout mice J Jawien, M Gajda, M Rudling, L Mateuszuk, R Olszanecki, TJ Guzik, ... European journal of clinical investigation 36 (3), 141-146, 2006 | 151 | 2006 |
Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis DS Skiba, R Nosalski, TP Mikolajczyk, M Siedlinski, FJ Rios, ... British Journal of Pharmacology 174 (22), 4055-4069, 2017 | 125 | 2017 |
Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats A Kawczynska-Drozdz, R Olszanecki, J Jawien, T Brzozowski, WW Pawlik, ... American journal of hypertension 19 (7), 764-767, 2006 | 116 | 2006 |
The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis J Jawien Current pharmaceutical biotechnology 13 (13), 2435-2439, 2012 | 115 | 2012 |
SUPEROXIDE DISMUTASE ACTIVITY AND EXPRESSION IN HUMAN TJ Guzik, R Olszanecki, J Sadowski, B Kapelak, P Rudzinski, A Jopek, ... Journal of Physiology and Pharmacology 56 (2), 313-323, 2005 | 75 | 2005 |
Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR-double knockout mice. J Jawień, M Gajda, Ł Mateuszuk, R Olszanecki, A Jakubowski, ... Journal of Physiology and Pharmacology: an Official Journal of the Polish …, 2005 | 73 | 2005 |
Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart A Jakubowski, S Chlopicki, R Olszanecki, J Jawien, M Lomnicka, ... Prostaglandins, leukotrienes and essential fatty acids 72 (2), 139-145, 2005 | 72 | 2005 |
Kaempferol, but not resveratrol inhibits angiotensin converting enzyme R Olszanecki, B Bujak-Gizycka, J Madej, M Suski, PP Wolkow, J Jawien, ... J Physiol Pharmacol 59 (2), 387-392, 2008 | 69 | 2008 |
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J Jawien, J Toton-Zuranska, M Gajda, A Niepsuj, A Gebska, K Kus, ... atherosclerosis 1, 4, 2012 | 65 | 2012 |
Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice J Jawien, G Csanyi, M Gajda, L Mateuszuk, M Lomnicka, R Korbut, ... European journal of pharmacology 556 (1-3), 129-135, 2007 | 59 | 2007 |
AVE 0991—Angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice J Toton-Zuranska, M Gajda, G Pyka-Fosciak, K Kus, M Pawlowska, ... Journal of Physiology and Pharmacology 61 (2), 181, 2010 | 54 | 2010 |
BAYx1005 attenuates atherosclerosis in apoE/LDLR-double knockout mice J Jawien, M Gajda, R Olszanecki, R Korbut Journal of Physiology and Pharmacology 58 (3), 583, 2007 | 51 | 2007 |
The current view on the role of leukotrienes in atherogenesis J Jawien, R Korbut Journal of Physiology and Pharmacology 61 (6), 647, 2010 | 46 | 2010 |
Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats B Lorkowska, M Bartus, M Franczyk, RB Kostogrys, J Jawien, ... Journal of Pharmacology and Experimental Therapeutics 317 (3), 1019-1026, 2006 | 38 | 2006 |
Interactions between human platelets and eosinophils are mediated by selectin-P J Jawieñ, S Chlopicki, RJ Gryglewski Polish journal of pharmacology 54 (2), 157-160, 2002 | 33 | 2002 |